Literature DB >> 12700061

Animal models of oxygen-induced retinopathy.

Ashima Madan1, John S Penn.   

Abstract

Retinopathy of prematurity (ROP) is a neovascularizing disease of the retina affecting premature infants. Much of our current knowledge regarding development of both normal and abnormal blood vessels in the retina has been obtained from animal models of retinopathy. The retina is an excellent organ for studying angiogenesis, since the progress of blood vessel growth can be monitored by angiography or fundoscopy. Also, the entire retinal vasculature can be viewed in flat-mounted retinal preparations. Although these animal models were previously used to study the gross aspects of vasculogenesis and angiogenesis, they are increasingly being used to identify the genes and molecular mechanisms involved in these processes. Knowledge gained from these studies can be applied to non-ocular angiogenic conditions. This paper provides historical perspective on the development and use of animal models of retinal neovascular disease since the 1950's and on the key studies that have led to our current understanding about the pathogenesis these conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700061     DOI: 10.2741/1056

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  38 in total

Review 1.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

3.  Ferrochelatase regulates retinal neovascularization.

Authors:  Sardar Pasha Sheik Pran Babu; Darcy White; Timothy W Corson
Journal:  FASEB J       Date:  2020-07-27       Impact factor: 5.191

4.  Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis.

Authors:  Michael I Dorrell; Edith Aguilar; Lea Scheppke; Faith H Barnett; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 5.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

Review 6.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 7.  The neurovascular retina in retinopathy of prematurity.

Authors:  Anne B Fulton; Ronald M Hansen; Anne Moskowitz; James D Akula
Journal:  Prog Retin Eye Res       Date:  2009-06-27       Impact factor: 21.198

Review 8.  Hereditary influences in oxygen-induced retinopathy in the rat.

Authors:  Peter van Wijngaarden; Helen M Brereton; Douglas J Coster; Keryn A Williams
Journal:  Doc Ophthalmol       Date:  2009-09-19       Impact factor: 2.379

9.  Development of an experimental model of proliferative retinopathy by intravitreal injection of VEGF165.

Authors:  Emmerson Badaro; Eduardo Amorim Novais; Kalil Abdala; Mikael Chun; Muller Urias; Paulo Augusto de Arruda Melo Filho; Michel Eid Farah; Eduardo Buchele Rodrigues
Journal:  J Ocul Pharmacol Ther       Date:  2014-07-16       Impact factor: 2.671

Review 10.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.